Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:58 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | CITADEL ADVISORS LLC | 5,406,089 7.6% | 1,819,325 (+50.72%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | EXPENSIFY INC EXFY | CITADEL ADVISORS LLC | 2,794,376 4% | 82,713 (+3.05%) | View |
| 2024-02-14 4:57 pm Sale | 13G | CATCHA INVT CORP CHAA | CITADEL ADVISORS LLC | 6,410 0.3% | -2,198,479 (-99.71%) | View |
| 2024-02-14 4:57 pm Sale | 13G | PROJECT ENERGY REIMAGINED ACQ. PEGR | CITADEL ADVISORS LLC | 172,489 1% | -2,043,562 (-92.22%) | View |
| 2024-02-14 4:57 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | CITADEL ADVISORS LLC | 108,240 0.3% | -1,639,151 (-93.81%) | View |
| 2024-02-14 4:57 pm Purchase | 13G | VENTYX BIOSCIENCES INC VTYX | CITADEL ADVISORS LLC | 4,279,553 7.3% | 490,758 (+12.95%) | View |
| 2024-02-14 4:57 pm Sale | 13G | VERA THERAPEUTICS INC VERA | CITADEL ADVISORS LLC | 43,447 0.1% | -1,948,106 (-97.82%) | View |
| 2024-02-14 4:57 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | CITADEL ADVISORS LLC | 2,161,902 6% | -2,014 (-0.09%) | View |
| 2024-02-14 4:57 pm Sale | 13G | LEXEO THERAPEUTICS INC LXEO | CITADEL ADVISORS LLC | 2,084,267 7.8% | -8,221 (-0.39%) | View |
| 2024-02-14 4:57 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | CITADEL ADVISORS LLC | 1,556,842 5.2% | 219,849 (+16.44%) | View |
| 2024-02-14 4:57 pm Sale | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | CITADEL ADVISORS LLC | 3,738,482 5.3% | -101,347 (-2.64%) | View |
| 2024-02-14 4:57 pm Sale | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | CITADEL ADVISORS LLC | 1,181,144 8.5% | -23 (-0.00%) | View |
| 2024-02-14 4:57 pm Sale | 13G | KORRO BIO INC KRRO | CITADEL ADVISORS LLC | 529,251 6.6% | -16,967 (-3.11%) | View |
| 2024-02-14 4:57 pm Purchase | 13G | AURA BIOSCIENCES INC AURA | CITADEL ADVISORS LLC | 3,631,494 7.4% | 894,441 (+32.68%) | View |
| 2024-02-14 4:57 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | CITADEL ADVISORS LLC | 2,458,958 6.5% | -293,237 (-10.65%) | View |
| 2024-02-14 4:57 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | CITADEL ADVISORS LLC | 3,072,587 5% | 91,263 (+3.06%) | View |
| 2024-02-14 4:57 pm Sale | 13G | IKENA ONCOLOGY INC IKNA | CITADEL ADVISORS LLC | 178,177 0.4% | -1,976,957 (-91.73%) | View |
| 2024-02-14 4:57 pm Sale | 13G | IMMUNEERING CORP IMRX | CITADEL ADVISORS LLC | 2,078,092 7.1% | -63,405 (-2.96%) | View |
| 2024-02-14 4:57 pm Sale | 13G | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | CITADEL ADVISORS LLC | 2,034,260 3.4% | -851,832 (-29.52%) | View |
| 2024-02-14 4:57 pm Purchase | 13G | ACRIVON THERAPEUTICS INC ACRV | CITADEL ADVISORS LLC | 1,649,664 7.4% | 15,515 (+0.95%) | View |